Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

OHI vs NHI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NHI Captures Overall Composite Edge (26.3 SELL vs 50.5 HOLD), While OHI Leads 5–1 on Growth & Valuation Pillars

NHI Overall Winner 6-Pillar Tally: OHI 5 – 1 NHI Matrix Metrics: OHI 5 – 5 NHI

As of Nov 16, 2026, National Health Investors (NHI) captures the overall head-to-head institutional edge over Omega Healthcare Investors Inc. (OHI) on higher Unified Composite conviction (26.3/100 SELL vs. 50.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while OHI wins 5–1 across the 6-pillar growth and valuation breakdown. OHI trades at $46.91 (22.6x Forward P/E, 62.6% operating margin) versus NHI at $61.97 (18.2x Forward P/E, 42.5% operating margin).

  • Composite vs. Pillar Nuance: While OHI currently prints a higher short-term Unified Composite Score (50.5/100 HOLD vs. NHI 26.3/100 SELL), NHI captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (42.5% vs. 62.6% operating margin) and revenue trajectory (+26.3% vs. -0.6% YoY).
  • Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OHI vs NHI
OHI NYSE
Omega Healthcare Investors Inc.
Real Estate Investment Trusts
$46.91
-0.29% 1D
Market Cap $15.0B
TTM Revenue $1.26B
Forward P/E 22.6x
Beta / 30D Vol -0.04β · 29% Vol
Unified Composite Score
50.5 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 71.0 Mom 41.7
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 50
RSI-14: 49.6 · SMA20: $47.08 · SMA50: $46.44
NHI NYSE Head-to-Head Winner
National Health Investors
Real Estate Investment Trusts
$61.97
-1.56% 1D
Market Cap $3.2B
TTM Revenue $459M
Forward P/E 18.2x
Beta / 30D Vol -0.21β · 34% Vol
Unified Composite Score
26.3 / 100 SELL
Tech 12.0 Fund 34.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 32
RSI-14: 32.1 · SMA20: $67.24 · SMA50: $67.11

6-Pillar Scorecard Institutional Category Breakdown (OHI 5 – 1 NHI)

Columns: Metric · OHI · NHI
1. Valuation Multiples NHI
Forward P/E 22.6x 18.2x
Trailing P/E 19.0x 4.6x
PEG Ratio 11.99x 4.76x
EV / Revenue 14.9x 6.9x
2. Growth & Scale OHI
Revenue Growth (YoY) -0.6% +26.3%
Earnings Growth (YoY) -55.4% N/A
TTM Revenue (USD) $1.26B $459M
Market Cap $15.0B $3.2B
3. Profitability & Quality OHI
Gross Margin 95.8% 71.2%
Operating Margin 62.6% 42.5%
Net Profit Margin 60.5% 151.8%
Return on Equity (ROE) 14.5% 38.6%
4. Balance Sheet & Cash Flow OHI
Cash Generation (TTM) $855M $292M EBITDA
Cash Flow Margin 67.9% 63.5% EBITDA Mgn
Net Cash / Leverage $3.83B Net Debt (0.73x D/E) $42.56 Book/Sh · 38.6% ROE
Dividend Yield 5.61% 5.60%
5. Options & Positioning OHI
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 26.9% (65th %ile) 19.1% (2nd %ile)
Put/Call OI Skew 0.71x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat OHI
OpEx & R&D Intensity 33.2% of Rev ($418M) 28.7% of Rev ($132M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OHI (5) vs NHI (5)
Institutional Metric OHI NHI Criterion Row Edge
Market Capitalization
Scale
$15.0B $3.2B Larger Scale OHI
Trailing P/E Ratio
Valuation
19.0x 4.6x Lower Multiple NHI
Forward P/E Ratio
Valuation
22.6x 18.2x Lower Multiple NHI
Revenue Growth (YoY)
Growth
-0.6% +26.3% Higher Growth NHI
Operating Margin (TTM)
Profitability
62.6% 42.5% Higher Margin OHI
Net Profit Margin
Profitability
60.5% 151.8% Higher Margin NHI
Return on Equity (ROE)
Capital Efficiency
14.5% 38.6% Higher ROE NHI
52-Week Range Position
Momentum
46% ($42–$52) 1% ($62–$91) Stronger Trend OHI
Beta / 30D Volatility
Risk Regime
-0.04β · 29% Vol -0.21β · 34% Vol Lower Realized Risk OHI
Unified Institutional Score
Composite Signal
50.5 / 100 (HOLD) 26.3 / 100 (SELL) Higher Composite OHI
Trailing 12M Revenue (USD)
Operating Scale
$1.26B $459M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.8% 71.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
11.99x PEG · 14.9x EV/Rev 4.76x PEG · 6.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$855M ($3.83B Net Debt (0.73x D/E)) $292M EBITDA ($42.56 Book/Sh · 38.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon OHI +9.29 pp
OHI: +2.79% · NHI: -6.5%
3M Horizon OHI +16.41 pp
OHI: +1.02% · NHI: -15.39%
6M Horizon OHI +15.43 pp
OHI: -2.91% · NHI: -18.34%
1Y Horizon OHI +27.33 pp
OHI: +7.97% · NHI: -19.36%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OHI vs NHI. Trailing 12-month operating profitability (OHI 62.6% vs NHI 42.5%) and valuation multiples (OHI 22.6x vs NHI 18.2x Forward P/E) are benchmarked directly in Pillar 4 below.

OHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.26B
Gross Margin95.8%
Op. Margin62.6%
ROE / Fwd P/E14.5% · 22.6x
NHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$459M
Gross Margin71.2%
Op. Margin42.5%
ROE / Fwd P/E38.6% · 18.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OHI CONSOLIDATION
80d in phase · OBV DISTRIBUTION
Current IV 26.9%
IV Percentile 65th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact OHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NHI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 19.1%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $15.0B market capitalization and 62.6% operating margin.
OpEx & R&D Reinvestment 33.2% of Rev ($418M)
90D Engineering Disclosures 0 Published
NHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.2B market capitalization and 42.5% operating margin.
OpEx & R&D Reinvestment 28.7% of Rev ($132M)
90D Engineering Disclosures 0 Published

Investor FAQ OHI vs NHI Key Questions & Quantitative Answers

As of Nov 16, 2026, National Health Investors (NHI) captures the overall head-to-head institutional edge over Omega Healthcare Investors Inc. (OHI) on higher Unified Composite conviction (26.3/100 SELL vs. 50.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while OHI wins 5–1 across the 6-pillar growth and valuation breakdown. OHI trades at $46.91 (22.6x Forward P/E, 62.6% operating margin) versus NHI at $61.97 (18.2x Forward P/E, 42.5% operating margin). Composite vs. Pillar Nuance: While OHI currently prints a higher short-term Unified Composite Score (50.5/100 HOLD vs. NHI 26.3/100 SELL), NHI captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (42.5% vs. 62.6% operating margin) and revenue trajectory (+26.3% vs. -0.6% YoY). Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

OHI leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with NHI at +26.3% YoY revenue growth and N/A YoY earnings growth on $459M TTM revenue (71.2% gross margin, 42.5% operating margin). On trailing 12-month operating scale, OHI generates $1.26B in USD-normalized revenue versus $459M for NHI. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 28.7% of Rev ($132M) (0 disclosures) for NHI.

NHI screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas NHI trades at 18.2x Forward P/E, 4.6x Trailing P/E, 4.76x PEG, and 6.9x EV/Revenue (63.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus NHI (38.6% ROE) capital efficiency.

In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, NHI carries 19.1% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.21β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.